MedPac to Congress: Make pharmas report all samples to HHS
MedPac, the congressional advisory commission on Medicare, has endorsed stringent transparency rules for drug, device and biologics manufacturers, including detailed reporting on drug samples with the aim of facilitating targeted counter-detailing.
The e-mail address(es) that you supply to use this service will only be used to send the requested article.